Healthcare Triangle Net Worth
Healthcare Triangle Net Worth Breakdown | HCTI |
Healthcare Triangle Net Worth Analysis
Healthcare Triangle's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Healthcare Triangle's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Healthcare Triangle's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Healthcare Triangle's net worth analysis. One common approach is to calculate Healthcare Triangle's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Healthcare Triangle's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Healthcare Triangle's net worth. This approach calculates the present value of Healthcare Triangle's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Healthcare Triangle's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Healthcare Triangle's net worth. This involves comparing Healthcare Triangle's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Healthcare Triangle's net worth relative to its peers.
Enterprise Value |
|
To determine if Healthcare Triangle is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Healthcare Triangle's net worth research are outlined below:
Healthcare Triangle had very high historical volatility over the last 90 days | |
Healthcare Triangle has some characteristics of a very speculative penny stock | |
Healthcare Triangle has high likelihood to experience some financial distress in the next 2 years | |
The company reported the previous year's revenue of 33.2 M. Net Loss for the year was (12.34 M) with profit before overhead, payroll, taxes, and interest of 4.16 M. | |
Healthcare Triangle currently holds about 1.36 M in cash with (1.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
Roughly 49.0% of the company shares are held by company insiders |
Healthcare Triangle uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Healthcare Triangle. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Healthcare Triangle's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
26th of March 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
Know Healthcare Triangle's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Healthcare Triangle is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Healthcare Triangle backward and forwards among themselves. Healthcare Triangle's institutional investor refers to the entity that pools money to purchase Healthcare Triangle's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Geode Capital Management, Llc | 2024-12-31 | 27.3 K | Two Sigma Securities, Llc | 2024-12-31 | 10.8 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 10 K | Tower Research Capital Llc | 2024-12-31 | 3.9 K | Sbi Securities Co Ltd | 2024-12-31 | 167 | Bank Of America Corp | 2024-12-31 | 24.0 | Creative Financial Designs Inc | 2024-12-31 | 2.0 | Two Sigma Investments Llc | 2024-12-31 | 0.0 | Ubs Group Ag | 2024-12-31 | 0.0 | Citadel Advisors Llc | 2024-09-30 | 0.0 |
Follow Healthcare Triangle's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.26 M.Market Cap |
|
Project Healthcare Triangle's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (2.34) | (2.22) | |
Return On Capital Employed | (6.78) | (6.44) | |
Return On Assets | (1.41) | (1.34) | |
Return On Equity | (26.38) | (25.06) |
When accessing Healthcare Triangle's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Healthcare Triangle's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Healthcare Triangle's profitability and make more informed investment decisions.
Evaluate Healthcare Triangle's management efficiency
Healthcare Triangle has return on total asset (ROA) of (0.6027) % which means that it has lost $0.6027 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.6196) %, meaning that it created substantial loss on money invested by shareholders. Healthcare Triangle's management efficiency ratios could be used to measure how well Healthcare Triangle manages its routine affairs as well as how well it operates its assets and liabilities. The Healthcare Triangle's current Return On Tangible Assets is estimated to increase to -2.22. The Healthcare Triangle's current Return On Capital Employed is estimated to increase to -6.44. As of now, Healthcare Triangle's Other Current Assets are increasing as compared to previous years. The Healthcare Triangle's current Intangible Assets is estimated to increase to about 5.2 M, while Total Current Assets are projected to decrease to under 5.1 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.13 | 0.11 | |
Tangible Book Value Per Share | (0.93) | (0.89) | |
Enterprise Value Over EBITDA | (4.12) | (3.92) | |
Price Book Value Ratio | 24.86 | 26.09 | |
Enterprise Value Multiple | (4.12) | (3.92) | |
Price Fair Value | 24.86 | 26.09 | |
Enterprise Value | 16.9 M | 16.1 M |
Understanding the operational decisions made by Healthcare Triangle management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue 0.2607 | Revenue | Quarterly Revenue Growth (0.69) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Healthcare Triangle insiders, such as employees or executives, is commonly permitted as long as it does not rely on Healthcare Triangle's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Healthcare Triangle insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mathiesen Jeffrey S over three months ago Insider Trading | ||
Mathiesen Jeffrey S over six months ago Insider Trading | ||
Bhuiyan Mohammad Jainal over six months ago Disposition of 50000 shares by Bhuiyan Mohammad Jainal of Healthcare Triangle at 0.394 subject to Rule 16b-3 | ||
Lakshmanan Kannappan over six months ago Acquisition by Lakshmanan Kannappan of 200000 shares of Healthcare Triangle at 0.001 subject to Rule 16b-3 | ||
Rosa David A over six months ago Acquisition by Rosa David A of 10000 shares of Healthcare Triangle at 1.78 subject to Rule 16b-3 | ||
Lakshmanan Kannappan over a year ago Disposition of 200000 shares by Lakshmanan Kannappan of Healthcare Triangle subject to Rule 16b-3 | ||
Bhuiyan Mohammad Jainal over a year ago Healthcare Triangle exotic insider transaction detected | ||
Rosa David A over a year ago Acquisition by Rosa David A of tradable shares of Healthcare Triangle subject to Rule 16b-3 |
Healthcare Triangle Earnings per Share Projection vs Actual
Healthcare Triangle Corporate Management
Shibu Kizhakevilayil | Head Director | Profile | |
Suresh Venkatachari | Pres Chairman | Profile | |
Lakshmanan Kannappan | Head Director | Profile | |
Kristi Lane | VP Management | Profile | |
Sudish Mogli | Consultant | Profile | |
Thyagarajan Ramachandran | Chief Officer | Profile | |
Michael Campana | Vice Marketing | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Healthcare Triangle. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Healthcare Stock please use our How to Invest in Healthcare Triangle guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthcare Triangle. If investors know Healthcare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthcare Triangle listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.17) | Revenue Per Share | Quarterly Revenue Growth (0.69) | Return On Assets | Return On Equity |
The market value of Healthcare Triangle is measured differently than its book value, which is the value of Healthcare that is recorded on the company's balance sheet. Investors also form their own opinion of Healthcare Triangle's value that differs from its market value or its book value, called intrinsic value, which is Healthcare Triangle's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthcare Triangle's market value can be influenced by many factors that don't directly affect Healthcare Triangle's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthcare Triangle's value and its price as these two are different measures arrived at by different means. Investors typically determine if Healthcare Triangle is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthcare Triangle's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.